top of page

Devyser was founded in 2004 in Stockholm, Sweden, specialises in the development of genetic diagnostic tests for hereditary diseases, oncology, and transplantation, based on multiplexed PCR and QF-PCR technology. Their non-invasive products are well intended for guided targeted cancer therapies, rapid pre-natal diagnostics and post-transplantation monitoring.

bottom of page